Marjan Rouzbahman

ORCID: 0000-0003-1928-7454 · 4 papers in corpus
preprint 2018
·doi:10.12688/f1000research.13863.1

Background: To elucidate potential markers of endometriosis and endometriosis-associated endometrioid and clear cell ovarian carcinomas using mass spectrometry-based proteomics. Methods: A total of 21 fresh, frozen tissues from patients …

preprint 2018
F1000Research ·doi:10.12688/f1000research.13863.2

Background: To elucidate potential markers of endometriosis and endometriosis-associated endometrioid and clear cell ovarian carcinomas using mass spectrometry-based proteomics. Methods: A total of 21 fresh, frozen tissues from patients dia…

article 2016
·doi:10.1158/1557-3265.ovca15-b13

Abstract Introduction and Objectives: It is evident that ovarian cancer (OvCa) is not a single disease but is made up of several distinct subtypes, including serous, endometrioid, clear cell and mucinous. The gold-standard biomarker CA125 p…

2012
The American journal of surgical pathology ·doi:10.1097/pas.0b013e31825fa931

Endometrial stromal sarcoma (ESS) characterized by YWHAE-FAM22 genetic fusion is histologically higher grade and clinically more aggressive than ESS with JAZF1-SUZ12 or equivalent genetic rearrangements, hence it is clinically important to …